News Headlines Article

5 things to watch in the Senate’s major drug price hearing
Modern Healthcare

The Senate Finance Committee is holding a high-profile hearing on Tuesday that will feature testimony from the CEOs of seven major drug companies: Pfizer, Sanofi, AstraZeneca, Bristol-Myers Squibb, Merck, Johnson & Johnson and AbbVie.

The hearing is the latest in a series held by the committee on high drug prices. Here are five topics to watch out for:

Transparency and rebates: Senate Finance Committee Chairman Chuck Grassley tweeted on Monday that the price people pay for prescription drugs is shrouded in secrecy, foreshadowing a likely line of questioning tomorrow at the hearing. Lawmakers in both parties have derided the lack of transparency that drug companies employ in setting list prices;